Shares of Diploma PLC (LON:DPLM) have been assigned a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target among brokers that have updated their coverage on the stock in the last year is GBX 1,364.17 ($17.83).
DPLM has been the subject of a number of research analyst reports. Peel Hunt reaffirmed an “add” rating and set a GBX 1,400 ($18.29) price objective on shares of Diploma in a research report on Monday, November 19th. Jefferies Financial Group reduced their target price on shares of Diploma from GBX 1,350 ($17.64) to GBX 1,320 ($17.25) and set a “buy” rating for the company in a research report on Monday, August 6th. Berenberg Bank reissued a “buy” rating and issued a GBX 1,365 ($17.84) target price on shares of Diploma in a research report on Thursday, September 6th. Barclays boosted their target price on shares of Diploma from GBX 1,190 ($15.55) to GBX 1,225 ($16.01) and gave the company an “equal weight” rating in a research report on Tuesday. Finally, Numis Securities boosted their target price on shares of Diploma from GBX 1,275 ($16.66) to GBX 1,355 ($17.71) and gave the company a “hold” rating in a research report on Wednesday, August 29th.
DPLM stock opened at GBX 1,296 ($16.93) on Monday. Diploma has a one year low of GBX 1,010 ($13.20) and a one year high of GBX 1,270 ($16.59).
The firm also recently announced a dividend, which will be paid on Wednesday, January 23rd. Stockholders of record on Thursday, November 29th will be given a GBX 17.80 ($0.23) dividend. This represents a dividend yield of 1.32%. The ex-dividend date is Thursday, November 29th. This is a boost from Diploma’s previous dividend of $7.70.
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through Life Sciences, Seals, and Controls business sectors. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology laboratories; electrosurgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.
Recommended Story: Bond
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.